Blood test could detect signs of Alzheimer’s ‘decades before symptoms’ – study The findings show that Alzheimer’s may be present in midlife and already linked to cognitive differences, researchers said. Evening Standard · May 28
The ‘Sweet’ Habit Researchers Say Could Raise Your Alzheimer’s Risk Many people think of sugary snacks as harmless comfort foods, especially during stressful days or late-night cravings. However, growing research suggests that regularly consuming large... Saving Advice · May 22
Blood biomarkers could detect earliest signs of Alzheimer’s disease – and slow its progression Alzheimer’s disease, a progressive neurodegenerative disorder that affects millions worldwide, has a long preclinical stage. It potentially begins decades before clinical symptoms become apparent. The Conversation · May 20
ACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth ACADIA Pharmaceuticals (NASDAQ:ACAD) executives used an RBC Capital Markets investor session to outline the company’s clinical rationale for remlifanserin in Alzheimer’s disease psychosis, provide updates on commercial trends for NUPLAZID and DAYBUE, and discuss selected pipeline and business develo MarketBeat · May 19
Risen Pharma Announces Initiation of Phase 2 Clinical Trial of RP902 for Mild Cognitive Impairment Due to Alzheimer’s Disease SHANGHAI, May 19, 2026 (GLOBE NEWSWIRE) -- Risen Pharma, a clinical-stage biotech company focusing on the development and commercialization of high-need, patient-accessible therapeutics, today announced the initiation of a Phase 2 clinical study in China of RP902, an oral small-molecule drug developed to address significant unmet medical needs in patients… AAP · May 19
Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch Axsome Therapeutics (NASDAQ:AXSM) executives said the company is preparing for a June launch of AUVELITY in Alzheimer’s disease agitation while continuing to expand its push in major depressive disorder, citing broad payer access, a larger sales force and what they described as a differentiated clin MarketBeat · May 12
Acumen Pharmaceuticals Q1 Earnings Call Highlights Acumen Pharmaceuticals (NASDAQ:ABOS) said its Phase 2 ALTITUDE-AD trial of sabirnetug remains on track, with top-line results expected late in 2026, as the company continues to advance its broader Alzheimer’s disease pipeline. On the company’s first-quarter 2026 earnings call, Chief Executive Offic MarketBeat · May 12
Eating eggs five times a week could slash Alzheimer’s risk While no diet can cure or reverse Alzheimer’s eggs contain nutrients that scientists believe can boost brain health The Independent UK · May 6
Scientists unveil Alzheimer’s finger prick test to predict risk of disease Researchers found the blood test can be used with computerised cognitive testing to identify a person’s risk of Alzheimer’s The Independent UK · May 6
The mouth-brain link: how healthy gums could help protect against Alzheimer’s disease Four tips for better oral health—which could mean better brain health too Fit & Well · May 3
I’m a ‘sandwich-generation’ caregiver. Chances are you will be, too Some 16 million Americans in mid-life caring for aging relatives and minor children at the same time - and those numbers are expected to grow significantly in the coming decades. America isn’t ready, Julia Musto discovers The Independent UK · Mar 29
The four types of dementia most people don’t know exist What most people think of when they hear the word “dementia” is memory problems and forgetfulness. But what people often don’t know is that dementia can cause many different symptoms – affecting speech, behaviour, sleep, motor function and more. The Conversation · Mar 26
Vagus nerve stimulation shows promise as a way to counter Alzheimer’s disease- and age-related memory loss Most people think of Alzheimer’s disease as an illness of aging. But in fact, the brain changes that characterize it begin much earlier – sometime around the third decade of life. The Conversation · Mar 26
NHS watchdog to review evidence on two pioneering Alzheimer’s drugs Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed their benefits “too small” to justify the cost The Independent UK · Mar 20
The Conversation · Mar 13 Hormone therapy and dementia risk: what a new study says about menopause treatment Hormone therapy is widely used to treat menopausal symptoms such as hot flushes and night sweats. But scientists have long debated whether it affects dementia risk.
Euronews · Mar 11 Reading, puzzles and learning new skills may help delay Alzheimer’s disease, study suggests Keeping your brain active throughout life by learning new skills or reading could help delay Alzheimer’s disease.
Sports Illustrated · Mar 10 Beyond the Slopes: Mikaela Shiffrin’s Mission to Help Educate Families Facing Early Symptomatic Alzheimer’s Disease Mikaela was compensated for her time by Eli Lilly and Company. The Most Decorated Skier of Our Time Mikaela Shiffrin knows what it means to chase down a challen
LiveScience · Mar 10 Single protein could dramatically alter trajectory of Alzheimer's disease In people destined to get Alzheimer's in their mid-40s, one protein can delay the onset of the disease by about 20 years.
The Independent UK · Mar 6 Researchers say AI can predict Alzheimer’s disease with close to 93 percent accuracy More than 7 million Americans are living with the degenerative neurological disorder
Medical Daily · Feb 23 Common Pneumonia Bacterium Found in the Eye May Contribute to Alzheimer's Disease Risk Research links pneumonia bacterium Alzheimer's risk through retinal infection and inflammation, expanding Alzheimer's disease risk factors.
The Guardian - UK · Feb 11 Reading and writing can lower dementia risk by almost 40%, study suggests Cognitive health in later life is ‘strongly influenced’ by lifelong exposure to intellectually stimulating environments, say researchers
The Independent UK · Feb 11 Books, writing and learning languages proven to slash Alzheimer’s risk Experts say maintaining an active brain can stave off a decline in crucial thinking skills and memory
The Independent UK · Jan 19 The finger prick blood test that could revolutionise Alzheimer’s diagnosis The test aims to pick up three proteins known to be associated with Alzheimer’s
The Independent UK · Jan 15 The common diabetes symptom linked to increased risk of Alzheimer’s disease A new study has found that people who experience post-meal blood sugar spikes are more likely to develop Alzheimer’s disease
The Guardian - UK · Jan 9 Alzheimer’s therapies should target a particular gene, researchers say Scientists at UCL say drug developers should focus on two risk-raising variants of the Apoe gene